COA T5E-GBF matches Uzorak's public record. So this test doesn't rest on our review alone — the lab confirms it too.
T5E-GBFNot on file for this certificate: sterility and heavy metals. A purity figure says nothing about those.
Label 30 mg · Lab measured 35.64 mg
119% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 8.9 mg using the measured mass, against 7.5 mg on the label — 19% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | T5E-GBF |
|---|---|
| Portal lookup | ✓ Lab-verified |
| PDF vs portal | Uzorak's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of Tirzepatide, performed by Uzorak on May 22, 2026. Reported purity: 99.86%. Net content: 35.64 mg against 30 mg labeled (119% of label). Tested content exceeds the labeled amount by 19%. Endotoxins: Under 10 EU / Vial (assay range 10-1000 EU/Vial). Batch S79-T30-001. Sample source: shop-provided. Certificate of analysis attached.


Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion